Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2023-43703
Vulnerability Information

Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
Os Commerce 4.12.56860 - Cross Site Scripting Reflected (XSS)
Source: NVD (National Vulnerability Database)
Vulnerability Description
Os Commerce is currently susceptible to a Cross-Site Scripting (XSS) vulnerability. This vulnerability allows attackers to inject JS through the "product_info[][name]" parameter, potentially leading to unauthorized execution of scripts within a user's web browser.
Source: NVD (National Vulnerability Database)
CVSS Information
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N
Source: NVD (National Vulnerability Database)
Vulnerability Type
在Web页面生成时对输入的转义处理不恰当(跨站脚本)
Source: NVD (National Vulnerability Database)
Vulnerability Title
osCommerce 跨站脚本漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
osCommerce是一套基于GNUGPL授权的开源在线购物电子商务解决方案。 osCommerce 存在跨站脚本漏洞,该漏洞源于容易受到跨站脚本(XSS)漏洞的影响,允许攻击者在用户的Web浏览器中执行未经授权的脚本。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
VendorProductAffected VersionsCPESubscribe
Os CommerceOs Commerce 4.12.56860 -
II. Public POCs for CVE-2023-43703
#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC
III. Intelligence Information for CVE-2023-43703
Please Login to view more intelligence information
IV. Related Vulnerabilities
V. Comments for CVE-2023-43703

No comments yet


Leave a comment